Post-myocardial infarction heart failure dysregulates the bone vascular niche.
Jedrzej HoffmannGuillermo LuxánWesley Tyler AbplanalpSimone-Franziska GlaserTina RasperAriane FischerMarion Muhly-ReinholzMichael PotenteBirgit AssmusDavid JohnAndreas Michael ZeiherStefanie DimmelerPublished in: Nature communications (2021)
The regulation of bone vasculature by chronic diseases, such as heart failure is unknown. Here, we describe the effects of myocardial infarction and post-infarction heart failure on the bone vascular cell composition. We demonstrate an age-independent loss of type H endothelium in heart failure after myocardial infarction in both mice and humans. Using single-cell RNA sequencing, we delineate the transcriptional heterogeneity of human bone marrow endothelium, showing increased expression of inflammatory genes, including IL1B and MYC, in ischemic heart failure. Endothelial-specific overexpression of MYC was sufficient to induce type H bone endothelial cells, whereas inhibition of NLRP3-dependent IL-1β production partially prevented the post-myocardial infarction loss of type H vasculature in mice. These results provide a rationale for using anti-inflammatory therapies to prevent or reverse the deterioration of bone vascular function in ischemic heart disease.
Keyphrases
- heart failure
- single cell
- endothelial cells
- bone mineral density
- left ventricular
- bone marrow
- acute heart failure
- rna seq
- soft tissue
- transcription factor
- bone loss
- cardiac resynchronization therapy
- atrial fibrillation
- nitric oxide
- oxidative stress
- anti inflammatory
- gene expression
- clinical trial
- poor prognosis
- cell proliferation
- stem cells
- metabolic syndrome
- high fat diet induced
- dna methylation
- brain injury
- high glucose
- subarachnoid hemorrhage
- nlrp inflammasome
- cerebral ischemia